Kodiak Sciences (KOD) Liabilities and Shareholders Equity (2017 - 2026)

Kodiak Sciences has reported Liabilities and Shareholders Equity for 10 years, with the latest figure at $306.0 million in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 2.72% year-over-year to $306.0 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 billion (down 19.56% YoY), and the FY2025 full-year result was $351.5 million, up 4.75% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $306.0 million, down from $351.5 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $850.3 million in Q1 2022, with the low at $218.1 million in Q3 2025.
• Historically, Liabilities and Shareholders Equity has averaged $485.6 million across 5 years, with a median of $434.8 million in 2024.
• The largest YoY upside for Liabilities and Shareholders Equity was 4.75% in 2025 against a maximum downside of 41.48% in 2025.
• Kodiak Sciences' Liabilities and Shareholders Equity stood at $666.6 million in 2022, then retreated by 28.09% to $479.4 million in 2023, then decreased by 30.0% to $335.6 million in 2024, then advanced by 4.75% to $351.5 million in 2025, then dropped by 12.95% to $306.0 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $306.0 million (Q1 2026), $351.5 million (Q4 2025), and $218.1 million (Q3 2025), per Business Quant data.